BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barak N. Betahistine: what's new on the agenda? Expert Opinion on Investigational Drugs 2008;17:795-804. [DOI: 10.1517/13543784.17.5.795] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Jain R, Yadav RK, Rather JA. Voltammetric assay of anti-vertigo drug betahistine hydrochloride in sodium lauryl sulphate. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2010;366:63-7. [DOI: 10.1016/j.colsurfa.2010.05.027] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
2 Mika K, Szafarz M, Sapa J, Kotańska M. Influence of betahistine repeated administration on a weight gain and selected metabolic parameters in the model of excessive eating in rats. Biomed Pharmacother 2021;141:111892. [PMID: 34229247 DOI: 10.1016/j.biopha.2021.111892] [Reference Citation Analysis]
3 Strasser A. Molecular modeling and QSAR-based design of histamine receptor ligands. Expert Opinion on Drug Discovery 2009;4:1061-75. [DOI: 10.1517/17460440903264972] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
4 Lian J, Huang XF, Pai N, Deng C. Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways. Psychoneuroendocrinology 2014;48:77-86. [PMID: 24992721 DOI: 10.1016/j.psyneuen.2014.06.010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
5 Deng C, Lian J, Pai N, Huang X. Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model. J Psychopharmacol 2012;26:1271-9. [DOI: 10.1177/0269881112449396] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 5.1] [Reference Citation Analysis]
6 Murdin L, Hussain K, Schilder AG. Betahistine for symptoms of vertigo. Cochrane Database Syst Rev 2016;:CD010696. [PMID: 27327415 DOI: 10.1002/14651858.CD010696.pub2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
7 Zheng J, Vasselli JR, King JF, King ML, We W, Fitzpatrick Z, Johnson WD, Finley JW, Martin RJ, Keenan MJ, Enright FM, Greenway FL. Using Caenorhabditis elegans as a Model for Obesity Pharmacology Development. Am J Ther 2016;23:e1363-70. [PMID: 24786852 DOI: 10.1097/MJT.0000000000000061] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
8 Murdin L, Sladen M, Williams H, Bamiou D, Bibas A, Kikidis D, Oiknonomou A, Kouris I, Koutsouris D, Pontoppidan NH. EHealth and Its Role in Supporting Audiological Rehabilitation: Patient Perspectives on Barriers and Facilitators of Using a Personal Hearing Support System With Mobile Application as Part of the EVOTION Study. Front Public Health 2022;9:669727. [DOI: 10.3389/fpubh.2021.669727] [Reference Citation Analysis]
9 Kang D, Jing Z, Li R, Hei G, Shao T, Li L, Sun M, Yang Y, Wang Y, Wang X, Long Y, Huang X, Wu R. Effect of Betahistine and Metformin on Antipsychotic-Induced Weight Gain: An Analysis of Two Clinical Trials. Front Psychiatry 2018;9:620. [PMID: 30542300 DOI: 10.3389/fpsyt.2018.00620] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
10 Zamergrad MV, Kunelskaya NL, Guseva AL, Amelin AV, Lilenko SV, Samartcev IN, Zaytseva OV, Melnikov OA, Voronov VA, Lyapin AV. [Betahistine in vestibular disorders: current concepts and perspectives]. Vestn Otorinolaringol 2021;86:73-81. [PMID: 33929156 DOI: 10.17116/otorino20218602173] [Reference Citation Analysis]
11 Gross C, Blasey CM, Roe RL, Allen K, Block TS, Belanoff JK. Mifepristone treatment of olanzapine-induced weight gain in healthy men. Adv Ther 2009;26:959-69. [PMID: 19888560 DOI: 10.1007/s12325-009-0070-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
12 Hathout RM, Nasr M. Transdermal delivery of betahistine hydrochloride using microemulsions: physical characterization, biophysical assessment, confocal imaging and permeation studies. Colloids Surf B Biointerfaces 2013;110:254-60. [PMID: 23732802 DOI: 10.1016/j.colsurfb.2013.05.007] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 5.6] [Reference Citation Analysis]
13 Wegner I, Hall DA, Smit AL, McFerran D, Stegeman I. Betahistine for tinnitus. Cochrane Database Syst Rev 2018;12:CD013093. [PMID: 30908589 DOI: 10.1002/14651858.CD013093.pub2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
14 Lian J, Huang X, Pai N, Deng C. Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications. Pharmacological Research 2016;106:51-63. [DOI: 10.1016/j.phrs.2016.02.011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
15 Barak N, Beck Y, Albeck JH. Betahistine decreases olanzapine-induced weight gain and somnolence in humans. J Psychopharmacol 2016;30:237-41. [DOI: 10.1177/0269881115626349] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
16 Provensi G, Blandina P, Passani MB. The histaminergic system as a target for the prevention of obesity and metabolic syndrome. Neuropharmacology 2016;106:3-12. [PMID: 26164344 DOI: 10.1016/j.neuropharm.2015.07.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]